APASL 2009上 Michael P Manns教授专访
丙肝是世界范围内的危害人类健康的主要疾病，其危害要远远超过艾滋病。丙肝是一种机体的慢性紊乱， 80%的人从这种紊乱发展为慢性感染。这种疾病几乎不会自愈，我们现在仅能治愈大约50%的患者，但很大程度上，这也要取决于患者的基因型和病毒载量。然而，现在我们已经有各种药物和诊断试剂来为患者制定个体化的治疗方案。
阅读数：2495详细阅读>>
国际肝病采访贾继东教授
APASL is one of the most important regional associations for the study of liver disease. It was established in the 1970s by Professor Okuda, Professor Lawrie Powell, and several other senior professors at that time. It was a very small group at the beginning but it has grown very rapidly during the last decade, especially during the past five years.
阅读数：1562详细阅读>>
国际肝病采访Shih-chang Wang教授
These techniques are very effective in the right patient and both have their place. Radioembolization is much more expensive than chemoembolization and it is not used as often. Typically, a patient will be given one, two or at most three radioembolization treatment. This is mainly because there are limitations to the actual dose that can be given to a patient, whereas it is often prominent for patients to be given up to ten or fifteen chemoembolization treatment over the course of their disease.
阅读数：1780详细阅读>>
